| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/29/2009 | CN101418046A TAT protein transduction modified NEP1-40 fusion protein and use thereof |
| 04/29/2009 | CN101418045A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN101418044A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN101418043A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN101418042A Separation and purification of recombinant human blood vessel endothelia cell growth factor, chemical labeling in vitro and use thereof |
| 04/29/2009 | CN101418040A Plant jasmonate acid signal transduction regulatory protein and coding gene and use thereof |
| 04/29/2009 | CN101418039A Novel antibacterial peptide and preparation method and use thereof |
| 04/29/2009 | CN101417134A Hyaluronic acid decorated novel tertiary structure non-virogene transmission system and use thereof |
| 04/29/2009 | CN101417126A New use of OMI protein and coding gene thereof |
| 04/29/2009 | CN100482802C Heat stable mutants of starch biosynthesis enzymes |
| 04/29/2009 | CN100482801C Promoters for expressing genes in fungal cell |
| 04/29/2009 | CN100482800C Steroselective preparation of cyclic L-amino acids |
| 04/29/2009 | CN100482799C Regulation of quinolate phosphoribosyl transferase expression |
| 04/29/2009 | CN100482798C Novel glucuse dehydrogenase and process for producing the dehydrogenase |
| 04/29/2009 | CN100482797C Plant fatty acid epoxygenase genes and uses therefor |
| 04/29/2009 | CN100482796C Expression of recombinant ox growth hormone in pichia pastoris |
| 04/29/2009 | CN100482795C IREN protein, its preparation and use |
| 04/29/2009 | CN100482794C Method for deciding pathogenic risk of medicament-induced granulocytopenia |
| 04/29/2009 | CN100482793C Characterization of the gsk-3 beta protein and methods of use thereof |
| 04/29/2009 | CN100482792C Hydantoin racemase |
| 04/29/2009 | CN100482791C Pectate lyase variants |
| 04/29/2009 | CN100482790C Variants with altered properties |
| 04/29/2009 | CN100482789C Electron donor system for enzymes and its use for the biochemical conversion of substrates |
| 04/29/2009 | CN100482788C High-yield recombinant influenza B virus strain and its application |
| 04/29/2009 | CN100482688C Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 04/29/2009 | CN100482687C Human 5-HT7 receptor promoter sequence |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482683C Active fragment of human glycine-rich protein and use thereof |
| 04/29/2009 | CN100482679C Process of purification of hCG and recombinant hCG purified by that method |
| 04/29/2009 | CN100482677C Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye |
| 04/29/2009 | CN100482676C N-oxy-group-contained lipids |
| 04/29/2009 | CN100482674C Reduction of dermal scarring |
| 04/29/2009 | CN100482283C Novel chimeric CD154 |
| 04/29/2009 | CN100482281C Method of treatment using anti-ErbB antibody-maytansinoid conjugates |
| 04/29/2009 | CN100482277C Calicheamicin derivative-carrier conjugates |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/28/2009 | US7525027 Plants and seeds of corn variety I113752 |
| 04/28/2009 | US7525024 Soybean variety XB35F07 |
| 04/28/2009 | US7525023 Soybean variety XB28K07 |
| 04/28/2009 | US7525022 Soybean variety XB21N07 |
| 04/28/2009 | US7525019 Soybean cultivar S060293 |
| 04/28/2009 | US7525018 Soybean cultivar 6733322 |
| 04/28/2009 | US7525017 Soybean variety 4614131 |
| 04/28/2009 | US7525016 Identification of syn-copalyl diphosphate synthase |
| 04/28/2009 | US7525015 Prevention of transgene escape in genetically modified perennials |
| 04/28/2009 | US7525014 Transgenic magnaporthe resistant rice; tissue engineering; horticulture |
| 04/28/2009 | US7525013 generating transgenic plantS comprising introducing into a somatic embryo, a polynucleotide encoding dihydrodipicolinate synthase (DHPS) polypeptide, effective to render the embryo resistant to S-2-aminoethylcysteine; herbicide resistance |
| 04/28/2009 | US7525012 Inducing plant somatic embryogenesis in absence of hormones using expression vector coding glucocorticoid and/or estrogen receptors and the regulatory proteins leafy cotyledon 1 (LEC1) and somatic embryogenesis receptor-like kinase (SERK) |
| 04/28/2009 | US7525011 Zebrafish animal models for clarifying gene function relationships in hyperproliferative disorders; antisense agents; RNA interference and tumor treatment therapies |
| 04/28/2009 | US7524949 Prevention or therapy of cardiovascular complications |
| 04/28/2009 | US7524948 Expression cassettes for vascular tissue-preferential expression in plants |
| 04/28/2009 | US7524947 Recombinant viral-based malaria vaccines |
| 04/28/2009 | US7524945 Comprises nucleotide sequences coding diacylglycerol acetyltransferases (DGAT) for transforming and generating plants with increased seed oil concentrations |
| 04/28/2009 | US7524944 polynucleotide encoding peptide domain of CD40 ligand lacking a matrix metalloproteinase cleavage sites, used as immunology modulators, vaccines and treatments of human diseases, including malignancies and autoimmune diseases |
| 04/28/2009 | US7524943 Using vector transformation to insert plasmid which express antisense sequences which reduce proanthocyanidin (PA) in plant seed coats; enhancing feed quality and digestibility |
| 04/28/2009 | US7524940 OB protein compositions and methods |
| 04/28/2009 | US7524936 labeled monoclonal or polyclonal antibodies that preferentially binds oxidoreductase enzyme polypeptides, proteins, fragments, domain peptides or amino acid sequences having replacements, capable of superoxide production |
| 04/28/2009 | US7524934 Human brain carboxypeptidase B antibodies |
| 04/28/2009 | US7524933 lyases enzymes obtained from transformed plant tissue expressing polynucleotide that encodes the polypeptide; improved ethanol biosynthesis, stalk and nodal strength |
| 04/28/2009 | US7524931 Full-length interferon gamma polypeptide variants |
| 04/28/2009 | US7524830 Decoy-containing pharmaceutical compositions and method of using the same |
| 04/28/2009 | US7524828 Immunostimulatory nucleic acid molecules |
| 04/28/2009 | US7524827 Two nucleotides containing 5-methylcytosine, the first hybridizing to the promoter region of a bcl-2 gene and the second hybridizing to a different type of oncogene; anticarcinogenic agents for melanomas, pancreatic, colon, breast, bladder, lung, leukemia, prostate, lymphoma, and ovarian cancers |
| 04/28/2009 | US7524816 Peptides and supported peptides for treating skin diseases |
| 04/28/2009 | US7524815 Bovine or colostrum; milk, yogurt, curd, cheese, fermented milks, milk-based fermented products, ice creams, fermented cereal-based products, milk-based powders, infant formula, pet food; Osteoporosis, Paget's Disease, hypercalcemia, bone loss from arthritis, necrosis, or periodontal disease |
| 04/28/2009 | US7524680 Polyampholytes for delivering polyions to a cell |
| 04/28/2009 | US7524678 Materials and methods for the alteration of enzyme and acetyl CoA levels in plants |
| 04/28/2009 | US7524677 Mammalian cultured inner cell mass cell culture using a g1 cell as nuclear donor |
| 04/28/2009 | US7524675 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis |
| 04/28/2009 | US7524674 Triple or double fusion vector harboring a Positron Emission Tomographic (PET), a bioluminescence and a fluorescence reporter gene that is imageable in living cells using a fluorescence microscope, a charge couple camera |
| 04/28/2009 | US7524669 Comprising a disrupted ACR3 gene; treating waste water containing heavy metal ion such as As; pollution control |
| 04/28/2009 | US7524667 Mutated 6-phosphogluconate dehydrogenase |
| 04/28/2009 | US7524666 Reductase gene and use thereof |
| 04/28/2009 | US7524665 Methods and compositions for vitamin K epoxide reductase |
| 04/28/2009 | US7524664 Regio- and enantioselective alkane hydroxylation with modified cytochrome P450 |
| 04/28/2009 | US7524660 Utilization of fructose in microbial production strains |
| 04/28/2009 | US7524657 Alleles of the sigA gene from coryneform bacteria |
| 04/28/2009 | US7524656 Ability to produce L-glutamic acid, arginine or lysine is incrreased by increasing expression of a specific protein, e.g., by increasing the copy number of the DNA coding for the protein |
| 04/28/2009 | US7524654 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 04/28/2009 | US7524653 Small interfering RNA libraries and methods of synthesis and use |
| 04/28/2009 | US7524649 Chimeric polypeptide having a modified binding domain of growth hormone linked to a receptor binding domain of growth hormone receptor; treating giantism; acromegaly; cancer diabetic retinopathy; diabetic nephropathy, diabetic complications and any disease of growth hormone excess |
| 04/28/2009 | US7524648 Expression system for enhancing solubility and immunogeneicity of recombinant proteins |
| 04/28/2009 | US7524647 Biosynthesis; orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases |
| 04/28/2009 | US7524646 Using mutant amino acid adaptor/carrier proteins to alter amino acid content of polypetides; directed protein evolution |
| 04/28/2009 | US7524645 Nucleic acid sequences of truncated or mutated alternansucrases, vectors containing these nucleic acids sequences, host cells transformed with the nucleic acid sequences; high level of expression while retaining enzymatic activity |
| 04/28/2009 | US7524644 Expression vector comprising enzymatic polypeptide for use in prevention and treatment of blood clots; thrombolytic agents |
| 04/28/2009 | US7524643 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant |
| 04/28/2009 | US7524642 Identifying modulators of ubiquitin-mediated proteolysis; treatment and prevention of cell proliferative, arthritic and respiratory system disorders |
| 04/28/2009 | US7524637 Nucleotide sequences coding g protein coupled receptors for identifying compounds block or enhance taste perception; food processing; improving taste of pharmeceuticals |
| 04/28/2009 | US7524633 Method of detection of prostate cancer |
| 04/28/2009 | US7524632 Species identification by melting analysis of secondary structure of single stranded nucleic acids |
| 04/28/2009 | US7524630 Silica-coated nanoparticles functionalized with biologically active molecules such as antibodies and nucleotides are used to label cells, to detect and isolate nucleic acid molecules having specific nucleotide sequences |
| 04/28/2009 | US7524627 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; generating and/or increasing an immunogenic response directed against Respiratory Syncytial Virus |
| 04/28/2009 | US7524626 Production of replication deficient retroviral vector particles from retroviruses which capable of transducing cells; gene therapy |
| 04/28/2009 | US7524524 For low fat spreads; fractionation, interesterification of blends of stearic acid and palmitic acid |
| 04/28/2009 | US7524508 Contain large deletions; vaccines against dengue virus infection; structural proteins encapsulate said subgenomic replicon |
| 04/28/2009 | US7524507 Enhancing expression of protein in gsstrointestinal mucosal cells of mammal by placing in recombinant gut-colonizing bacterium (Salmonella), attenuated so mammal does not experience significant harmful infectious effects; vaccines |
| 04/28/2009 | US7524506 gM-negative EHV-mutants without heterologous elements |
| 04/28/2009 | US7524503 Antigens; vaccines; isolated peptide |
| 04/28/2009 | US7524502 Modified anti-TNF alpha antibody |